|
|
Star Scientific Incorporated - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Star Scientific Incorporated. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Star Scientific Incorporated. The Group's principal activities are to develop, implement, manufacture, sell, market and license of proprietary technology for the curing of tobacco to prevent the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines. It develops pharmaceutical products, particularly products that have a botanical, tobacco-based component, that are designed to treat tobacco dependence and a range of neurological conditions, including Alzheimer's disease, Parkinson's disease, schizophrenia and depression and potentially related products such as neutraceuticals. The Group operates in the United States.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|